Cargando…
Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib
BACKGROUND: Serial analysis of biomarkers in the circulation of patients undergoing treatment (“liquid biopsies”) can provide new insights into drug effects. In particular the analysis of cell-free, circulating nucleic acids such as microRNAs (miRs) can reveal altered expression patterns indicative...
Autores principales: | Shivapurkar, Narayan, Vietsch, Eveline E., Carney, Erin, Isaacs, Claudine, Wellstein, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628092/ https://www.ncbi.nlm.nih.gov/pubmed/28980224 http://dx.doi.org/10.1186/s40169-017-0169-y |
Ejemplares similares
-
Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors
por: Peran, Ivana, et al.
Publicado: (2022) -
Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs
por: Shivapurkar, Narayan, et al.
Publicado: (2014) -
Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer
por: Vietsch, Eveline E, et al.
Publicado: (2015) -
Correction: Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs
por: Shivapurkar, Narayan, et al.
Publicado: (2014) -
Circulating biomarkers to monitor cancer progression and treatment
por: Rapisuwon, Suthee, et al.
Publicado: (2016)